Ready for the good news? Less than 50% of patients with cutaneous reactions after the first dose experienced second dose recurrence. None reported serious adverse events. #dermtwitter#MedTwitter
The most common morphologies were delayed large local reactions, local injection site reactions, urticaria, and morbilliform eruptions. jaad.org/article/S0190-…
Bottom line? If rash starts >4 hours after first vaccination, then fine to proceed with second vaccine dose. #dermtwitter#MedTwitter
You know what else is really interesting? We also saw pernio/chilblains #COVIDtoes after #COVIDvaccines, suggesting that a) the host immune response to the virus is being replicated by vaccine and b) #covidtoes may be from immune response to the virus #dermtwitter@USATODAY
It’s come to our attention that there is a glitch on the publisher’s website they are trying to fix, which is only showing half the paper @JAADjournals. Here is where you can access the entire PDF: #dermtwitterjaad.org/article/S0190-…
It’s come to our attention that there is a glitch on the publisher’s website, and some readers were only able to access half of the paper. Here’s the full paper on 414 #COVID19#vaccine skin reactions: jaad.org/article/S0190-…#dermtwitter
• • •
Missing some Tweet in this thread? You can try to
force a refresh